JP2015505314A5 - - Google Patents

Download PDF

Info

Publication number
JP2015505314A5
JP2015505314A5 JP2014551232A JP2014551232A JP2015505314A5 JP 2015505314 A5 JP2015505314 A5 JP 2015505314A5 JP 2014551232 A JP2014551232 A JP 2014551232A JP 2014551232 A JP2014551232 A JP 2014551232A JP 2015505314 A5 JP2015505314 A5 JP 2015505314A5
Authority
JP
Japan
Prior art keywords
subject
pioglitazone
alzheimer
disease
risk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014551232A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015505314A (ja
Filing date
Publication date
Priority claimed from PCT/US2012/020606 external-priority patent/WO2012096873A1/en
Application filed filed Critical
Priority claimed from PCT/US2012/046692 external-priority patent/WO2013106084A1/en
Publication of JP2015505314A publication Critical patent/JP2015505314A/ja
Publication of JP2015505314A5 publication Critical patent/JP2015505314A5/ja
Pending legal-status Critical Current

Links

JP2014551232A 2012-01-09 2012-07-13 アルツハイマー病を治療する方法及び医薬品 Pending JP2015505314A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
PCT/US2012/020606 WO2012096873A1 (en) 2011-01-10 2012-01-09 Methods and drug products for treating alzheimer's disease
US13/346,081 US9102666B2 (en) 2011-01-10 2012-01-09 Methods and drug products for treating Alzheimer's disease
USPCT/US2012/020606 2012-01-09
US13/346,081 2012-01-09
US201261659872P 2012-06-14 2012-06-14
US61/659,872 2012-06-14
PCT/US2012/046692 WO2013106084A1 (en) 2012-01-09 2012-07-13 Methods and drug products for treating alzheimer's disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017111243A Division JP2017197554A (ja) 2012-01-09 2017-06-06 アルツハイマー病を治療する方法及び医薬品

Publications (2)

Publication Number Publication Date
JP2015505314A JP2015505314A (ja) 2015-02-19
JP2015505314A5 true JP2015505314A5 (enExample) 2015-09-03

Family

ID=48781795

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014551232A Pending JP2015505314A (ja) 2012-01-09 2012-07-13 アルツハイマー病を治療する方法及び医薬品
JP2017111243A Pending JP2017197554A (ja) 2012-01-09 2017-06-06 アルツハイマー病を治療する方法及び医薬品

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017111243A Pending JP2017197554A (ja) 2012-01-09 2017-06-06 アルツハイマー病を治療する方法及び医薬品

Country Status (2)

Country Link
JP (2) JP2015505314A (enExample)
WO (1) WO2013106084A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160345855A1 (en) * 2013-12-13 2016-12-01 Northwestern University Methods of treating brain disorders or identifying biomarkers related thereto
JP2017001989A (ja) * 2015-06-11 2017-01-05 ニプロ株式会社 医薬組成物の製造方法及び医薬組成物
GB201810492D0 (en) * 2018-06-27 2018-08-08 Cordeiro Maria Francesca Composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191154B1 (en) * 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
US8846315B2 (en) * 2008-08-12 2014-09-30 Zinfandel Pharmaceuticals, Inc. Disease risk factors and methods of use
KR20160127181A (ko) * 2008-08-12 2016-11-02 진판델 파마슈티컬스 인코포레이티드 질환 위험 인자의 식별 방법
CN107362165A (zh) * 2011-01-10 2017-11-21 金帆德尔制药股份有限公司 用于治疗阿尔茨海默病的方法和药物产品

Similar Documents

Publication Publication Date Title
CN111065394B (zh) 中枢神经系统病症的治疗
Cummings et al. Pimavanserin: potential treatment for dementia-related psychosis
JP7312169B2 (ja) 遺伝性てんかん性障害の処置に使用するガナキソロン
Yang et al. Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and lower dosages of rituximab among patients with neuromyelitis optica spectrum disorder
Fava et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder
Dupuis et al. A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis
RU2770050C2 (ru) Способ лечения с применением традипитанта
EP3512506B1 (en) Use of pridopidine for treating rett syndrome
CA3083341C (en) Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
US20220162610A1 (en) Novel rna transcript
Łuc et al. Tackling Alzheimer's disease: Hypothetical synergism between anti-inflammatory and anti-diabetic agents
US20190276560A1 (en) Composition and method for treating alzheimer's disease
JP2016528171A5 (enExample)
Swerdlow et al. A pilot Study of oxaloacetate 100 mg capsules in Parkinson’s disease patients
CN104906501A (zh) 治疗银屑病的中药组分组合物
US20240409928A1 (en) Novel rna transcript
Baba et al. Seven cases of late-life depression treated with cilostazol-augmented therapy
Lin et al. FRI0159 REAL-WORLD EVIDENCE OF EFFECTIVENESS OF SWITCHING FROM TOFACITINIB 5MG BID TO TOFACITINIB 11MG QD IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS: A SINGLE-CENTER, OBSERVATIONAL STUDY IN TAIWAN
Praharaj et al. Sertraline-induced facial paresthesia
Rabinowitz et al. P. 3. a. 012 Age of onset of schizophrenia and outcomes in 29 placebo-controlled RCT's of antipsychotics in the NEWMEDS repository
Bell et al. P1‐445: Early evaluation of the safety, tolerability and pharmacokinetics of a novel 5HT6 receptor full antagonist for the treatment of the symptoms of mild‐to‐moderate dementia of the Alzheimer type
Frogley et al. Poster# 216 A RETROSPECTIVE STUDY OF CLOZAPINE IN EMOTIONALLY UNSTABLE PERSONALITY DISORDER
CN108938645A (zh) 一种抗精神病药物组合物
Mizuno P. 3. c. 014 Antiepileptics ameliorated acute psychosis in a patient with Klinefelter's syndrome
Okahisa et al. P. 3. c. 015 Improvement of serum prolactin after switching to blonanserin from risperidone in patients with schizophrenia: report of four cases